These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31497639)

  • 1. Nanomaterial Interactions with Human Neutrophils.
    Bisso PW; Gaglione S; Guimarães PPG; Mitchell MJ; Langer R
    ACS Biomater Sci Eng; 2018 Dec; 4(12):4255-4265. PubMed ID: 31497639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-Particle Interactions in Blood Circulation Drive Particle Clearance and Alter Neutrophil Responses in Acute Inflammation.
    Fromen CA; Kelley WJ; Fish MB; Adili R; Noble J; Hoenerhoff MJ; Holinstat M; Eniola-Adefeso O
    ACS Nano; 2017 Nov; 11(11):10797-10807. PubMed ID: 29028303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils.
    Kelley WJ; Fromen CA; Lopez-Cazares G; Eniola-Adefeso O
    Acta Biomater; 2018 Oct; 79():283-293. PubMed ID: 30195083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle uptake driven phagocytosis in macrophages and neutrophils enhances bacterial clearance.
    Sharma P; Vijaykumar A; Raghavan JV; Rananaware SR; Alakesh A; Bodele J; Rehman JU; Shukla S; Wagde V; Nadig S; Chakrabarti S; Visweswariah SS; Nandi D; Gopal B; Jhunjhunwala S
    J Control Release; 2022 Mar; 343():131-141. PubMed ID: 35085696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils preferentially phagocytose elongated particles-An opportunity for selective targeting in acute inflammatory diseases.
    Safari H; Kelley WJ; Saito E; Kaczorowski N; Carethers L; Shea LD; Eniola-Adefeso O
    Sci Adv; 2020 Jun; 6(24):eaba1474. PubMed ID: 32577517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-in-Micro-Particles Consisting of PLGA Nanoparticles Embedded in Chitosan Microparticles via Spray-Drying Enhances Their Uptake in the Olfactory Mucosa.
    Spindler LM; Feuerhake A; Ladel S; Günday C; Flamm J; Günday-Türeli N; Türeli E; Tovar GEM; Schindowski K; Gruber-Traub C
    Front Pharmacol; 2021; 12():732954. PubMed ID: 34539414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil mediated drug delivery for targeted glioblastoma therapy: A comprehensive review.
    Hosseinalizadeh H; Mahmoodpour M; Razaghi Bahabadi Z; Hamblin MR; Mirzaei H
    Biomed Pharmacother; 2022 Dec; 156():113841. PubMed ID: 36411657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic additives in nanosystems activate cytotoxicity and inflammatory response of human neutrophils: lipid nanoparticles versus polymeric nanoparticles.
    Hwang TL; Aljuffali IA; Lin CF; Chang YT; Fang JY
    Int J Nanomedicine; 2015; 10():371-85. PubMed ID: 25609950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation.
    Saito E; Kuo R; Pearson RM; Gohel N; Cheung B; King NJC; Miller SD; Shea LD
    J Control Release; 2019 Apr; 300():185-196. PubMed ID: 30822435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats.
    Simon LC; Sabliov CM
    Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicokinetics of Nanoparticles Deposited in Lungs Using Occupational Exposure Scenarios.
    Creutzenberg O; Pohlmann G; Schaudien D; Kock H
    Front Public Health; 2022; 10():909247. PubMed ID: 35801236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.
    Roberts RA; Shen T; Allen IC; Hasan W; DeSimone JM; Ting JP
    PLoS One; 2013; 8(4):e62115. PubMed ID: 23593509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleic acid-based nanosystems for mitigating acute respiratory distress syndrome in mice through neutrophil suppression: how the particulate size affects therapeutic efficiency.
    Yu HP; Liu FC; Umoro A; Lin ZC; Elzoghby AO; Hwang TL; Fang JY
    J Nanobiotechnology; 2020 Jan; 18(1):25. PubMed ID: 32005196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Size on the Biodistribution and Blood Clearance of Etoposide-Loaded PLGA Nanoparticles.
    Yadav KS; Chuttani K; Mishra AK; Sawant KK
    PDA J Pharm Sci Technol; 2011; 65(2):131-9. PubMed ID: 21502074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(lactic-
    Maghrebi S; Joyce P; Jambhrunkar M; Thomas N; Prestidge CA
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):8030-8039. PubMed ID: 32013379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.
    Thomas C; Gupta V; Ahsan F
    Pharm Res; 2010 May; 27(5):905-19. PubMed ID: 20232117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammation.
    Gosens I; Post JA; de la Fonteyne LJ; Jansen EH; Geus JW; Cassee FR; de Jong WH
    Part Fibre Toxicol; 2010 Dec; 7(1):37. PubMed ID: 21126342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
    Silva AL; Rosalia RA; Varypataki E; Sibuea S; Ossendorp F; Jiskoot W
    Vaccine; 2015 Feb; 33(7):847-54. PubMed ID: 25576216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytic Uptake of Polymeric Particles by Immune Cells under Flow Conditions.
    Srinivas M; Sharma P; Jhunjhunwala S
    Mol Pharm; 2021 Dec; 18(12):4501-4510. PubMed ID: 34748349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.